Ho, C. S., Feng, P.-J., Narita, M., Stout, J. E., Chen, M., Pascopella, L., … Tuberculosis Epidemiologic Studies Consortium, . (2022). Discordant results of tests for tuberculosis reconsidered - Authors' reply. Lancet Infect Dis, 22(2), 164–165. https://doi.org/10.1016/S1473-3099(21)00805-7

Ho, Christine S., Pei-Jean Feng, Masahiro Narita, Jason E. Stout, Michael Chen, Lisa Pascopella, Richard Garfein, Randall Reves, Dolly J. Katz, and Dolly J. Tuberculosis Epidemiologic Studies Consortium. “Discordant results of tests for tuberculosis reconsidered - Authors' reply.” Lancet Infect Dis 22, no. 2 (February 2022): 164–65. https://doi.org/10.1016/S1473-3099(21)00805-7.

Ho CS, Feng P-J, Narita M, Stout JE, Chen M, Pascopella L, et al. Discordant results of tests for tuberculosis reconsidered - Authors' reply. Lancet Infect Dis. 2022 Feb;22(2):164–5.

Ho, Christine S., et al. “Discordant results of tests for tuberculosis reconsidered - Authors' reply.” Lancet Infect Dis, vol. 22, no. 2, Feb. 2022, pp. 164–65. Pubmed, doi:10.1016/S1473-3099(21)00805-7.

Ho CS, Feng P-J, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ, Tuberculosis Epidemiologic Studies Consortium. Discordant results of tests for tuberculosis reconsidered - Authors' reply. Lancet Infect Dis. 2022 Feb;22(2):164–165.